<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Romano, Stefano</style></author><author><style face="normal" font="default" size="100%">Mastrolia, Maria Vincenza</style></author><author><style face="normal" font="default" size="100%">Bracaglia, Claudia</style></author><author><style face="normal" font="default" size="100%">Minoia, Francesca</style></author><author><style face="normal" font="default" size="100%">Giani, Teresa</style></author><author><style face="normal" font="default" size="100%">Caiello, Ivan</style></author><author><style face="normal" font="default" size="100%">Maccora, Ilaria</style></author><author><style face="normal" font="default" size="100%">Rossano, Martina</style></author><author><style face="normal" font="default" size="100%">Maniscalco, Valerio</style></author><author><style face="normal" font="default" size="100%">Marrani, Edoardo</style></author><author><style face="normal" font="default" size="100%">Pagnini, Ilaria</style></author><author><style face="normal" font="default" size="100%">Simonini, Gabriele</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Hepatic Involvement in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Clinical and Therapeutic Insights From 2 Cases</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of Rheumatology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-07-15 04:00:24</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">jrheum.2026-0131</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.3899/jrheum.2026-0131</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">We read with interest the manuscript entitled "Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome" by Eloseily et al,1 describing 4 patients with systemic juvenile idiopathic arthritis (sJIA) complicated by macrophage activation syndrome (MAS) and hepatic involvement and treated with emapalumab. We report our experience with this subgroup of patients, describing 2 cases treated at Meyer Children's Hospital in which patients experienced multiple hepatic relapses requiring a combined treatment approach.</style></abstract></record></records></xml>